Skip to main content
Fig. 4 | Breast Cancer Research

Fig. 4

From: Simultaneous targeting of HER family pro-survival signaling with Pan-HER antibody mixture is highly effective in TNBC: a preclinical trial with PDXs

Fig. 4

Analysis of HER family members and associated signaling pathways. Untreated PDX tumor models were analyzed by Western blot to determine the basal, initial levels of expression of HER family members EGFR and HER3, as well as associated signaling pathways including pEGFR, pHER3, PTEN, and FAK. A representative image is shown

Back to article page

Breast Cancer Research

ISSN: 1465-542X

Contact us